- testing |
₹42,043.95
(858.54)
(2.08%)
03 Feb , 2026 | 04:14 PM
Open
₹42,770.5
Prev. Close
₹41,185.4
Market Cap.
₹0
Div Yield
0
PE
0
PB
0
₹41,973.3
₹42,770.5
Performance
One Week (%)
-0.4
One Month (%)
-6.9
One Year (%)
1.74
YTD (%)
2.81
Company Name | CMP | High | Low | Volume |
|---|---|---|---|---|
Abbott India Ltd | 26,880 | 27,910 | 26,800 | 10,469 |
Glaxosmithkline Pharmaceuticals Ltd | 2,435.3 | 2,475.6 | 2,401.8 | 89,069 |
J B Chemicals & Pharmaceuticals Ltd | 1,895.7 | 1,931.7 | 1,880 | 1,63,839 |
Pfizer Ltd | 4,667.6 | 4,710.1 | 4,560.6 | 10,154 |
Lupin Ltd | 2,185.9 | 2,225 | 2,163.7 | 12,52,989 |
Ipca Laboratories Ltd | 1,435.3 | 1,470 | 1,423.8 | 2,07,460 |
Neuland Laboratories Ltd | 13,370 | 13,893 | 13,304 | 34,009 |
Aurobindo Pharma Ltd | 1,226.1 | 1,247.3 | 1,211.2 | 28,27,489 |
Natco Pharma Ltd | 853.7 | 880.5 | 845.05 | 5,81,622 |
Wockhardt Ltd | 1,350.1 | 1,397.1 | 1,330 | 6,26,285 |
Granules India Ltd | 571.8 | 589.35 | 565.15 | 8,18,433 |
Ajanta Pharma Ltd | 2,880.1 | 2,889 | 2,785.1 | 1,19,919 |
Poly Medicure Ltd | 1,586.9 | 1,598.3 | 1,524 | 3,68,301 |
Gland Pharma Ltd | 1,895.7 | 1,984.9 | 1,882.9 | 3,81,304 |
Biocon Ltd | 372.3 | 387.7 | 370.9 | 48,40,490 |
Alkem Laboratories Ltd | 5,702.5 | 5,747 | 5,628 | 1,75,751 |
Glenmark Pharmaceuticals Ltd | 1,954.2 | 2,006.6 | 1,947.6 | 5,35,670 |
Fortis Healthcare Ltd | 863.1 | 870.95 | 852.15 | 19,95,886 |
Syngene International Ltd | 478 | 512.95 | 474.55 | 19,91,438 |
Global Health Ltd | 1,113.2 | 1,160 | 1,104 | 2,36,152 |
Krishna Institute of Medical Sciences Ltd | 616.95 | 625 | 598.1 | 3,20,264 |
Rainbow Childrens Medicare Ltd | 1,114.5 | 1,172 | 1,111 | 3,26,534 |
Mankind Pharma Ltd | 2,162.6 | 2,190.2 | 2,112.3 | 7,78,709 |
Dr Lal Pathlabs Ltd | 1,405.8 | 1,443.8 | 1,390 | 2,91,370 |
Narayana Hrudayalaya Ltd | 1,754.4 | 1,809.9 | 1,738 | 4,03,177 |
Laurus Labs Ltd | 975.6 | 1,020 | 969.9 | 19,22,427 |
Aster DM Healthcare Ltd | 546.7 | 586.9 | 544.3 | 16,43,122 |
Cohance Lifesciences Ltd | 380.65 | 399.45 | 378 | 2,78,059 |
Piramal Pharma Ltd | 161.23 | 166.56 | 160.02 | 38,31,082 |
OneSource Specialty Pharma Ltd | 1,177.6 | 1,254.5 | 1,172.2 | 3,94,572 |
Sector-wise, the Metal index emerged as a standout performer, witnessing a substantial 4% surge.
1 Mar 2024|03:40 PM
This revision applies to all Bank Nifty contracts, including weekly, monthly, and quarterly, shifting their expiry to Wednesdays
1 Mar 2024|09:57 AM
Bharat Highways InvIT, which boasts a portfolio of seven road assets, launched the IPO with the goal of raising ₹2,500 Crore
29 Feb 2024|11:42 AM
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2026, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor), PFRDA Reg. No. PoP 20092018
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
